Profound Medical Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers the 2026 Annual General and Special Meeting of Shareholders held on May 13, 2026. Profound Medical Corp. is incorporated in Ontario, Canada, and its common shares trade on The Nasdaq Stock Market under the symbol "PROF."
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and shareholder voting results.
Material Changes and Voting Results
Shareholders voted on three primary matters:
- Election of Directors: All eight nominees were elected. Support varied among candidates:
- Frank Baylis (91.473%), Thomas Wellner (91.495%), Vafa Jamali (91.046%), and Arun Menawat (90.257%) received strong support.
- Brian Ellacott (81.554%), Cynthia Lavoie (81.873%), and Murielle Lortie (81.872%) received moderate support.
- Arthur Rosenthal received the lowest support at 78.999% (21.001% withheld).
- Appointment of Auditors: Shareholders overwhelmingly approved the appointment of PricewaterhouseCoopers LLP (99.497% For).
- Long-Term Incentive Plan: Shareholders approved an ordinary resolution regarding unallocated restricted share units and deferred share units. The vote was split, with 63.922% For and 36.078% Against.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, management commentary on operations, or specific risk factors. The document serves as a record of the shareholder meeting outcomes.
Investor Verification Checklist
- Verify the specific reasons for the 21.001% vote withholding for director nominee Arthur Rosenthal.
- Review the Management Information Circular (Exhibit 99.1) for details on the Long-Term Incentive Plan that received 36.078% opposition.
- Confirm the remuneration for PricewaterhouseCoopers LLP, which was noted as to be fixed by the Board.
- Check subsequent filings for the Company's latest financial performance, as this 8-K contains no financial data.